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Phenotypic Switching of Adipose Tissue Macrophages
With Obesity Is Generated by Spatiotemporal Differences
in Macrophage Subtypes
Carey N. Lumeng,1,2,3 Jennifer B. DelProposto,1 Daniel J. Westcott,1 and Alan R. Saltiel1,3,4
OBJECTIVE—To establish the mechanism of the phenotypic
switch of adipose tissue macrophages (ATMs) from an alterna-
tively activated (M2a) to a classically activated (M1) phenotype
with obesity.
RESEARCH DESIGN AND METHODS—ATMs from lean and
obese (high-fat diet–fed) C57Bl/6 mice were analyzed by a
combination of flow cytometry, immunofluorescence, and ex-
pression analysis for M2a and M1 genes. Pulse labeling of ATMs
with PKH26 assessed the recruitment rate of ATMs to spatially
distinct regions.
RESULTS—Resident ATMs in lean mice express the M2a
marker macrophage galactose N-acetyl-galactosamine specific
lectin 1 (MGL1) and localize to interstitial spaces between
adipocytes independent of CCR2 and CCL2. With diet-induced
obesity, MGL1 ATMs remain in interstitial spaces, whereas a
population of MGL1CCR2 ATMs with high M1 and low M2a
gene expression is recruited to clusters surrounding necrotic
adipocytes. Pulse labeling showed that the rate of recruitment of
new macrophages to MGL1 ATM clusters is significantly faster
than that of interstitial MGL1 ATMs. This recruitment is atten-
uated in Ccr2/ mice. M2a- and M1-polarized macrophages
produced different effects on adipogenesis and adipocyte insulin
sensitivity in vitro.
CONCLUSIONS—The shift in the M2a/M1 ATM balance is
generated by spatial and temporal differences in the recruitment
of distinct ATM subtypes. The obesity-induced switch in ATM
activation state is coupled to the localized recruitment of an
inflammatory ATM subtype to macrophage clusters from the
circulation and not to the conversion of resident M2a macro-
phages to M1 ATMs in situ. Diabetes 57:3239–3246, 2008
Obesity activates inflammatory pathways in leu-kocytes that contribute to the pathogenesis ofobesity-associated diseases, such as type 2 di-abetes and atherosclerosis. In particular, adi-
pose tissue macrophages (ATMs) have been identified as
the primary source of inflammatory cytokine production in
adipose tissue and a key component in the progression to
insulin resistance with obesity. ATMs are increased in
visceral fat depots with obesity and correlate with mea-
sures of insulin resistance (1). A range of mouse models
with loss-of-function mutations in genes important in
macrophage recruitment (Ccr2), inflammatory cytokine
production (Tnf), and proinflammatory activation (Ikk)
have demonstrated protection from high-fat diet–induced
insulin resistance (2–4).
Despite these advances, the function of ATMs in lean
and obese states is poorly understood. It has been sug-
gested that ATMs influence a range of processes in adipose
tissue, including adipogenesis, angiogenesis, and the re-
sponse to hypoxia (5–7). One potential clue to understand-
ing these diverse functions emerges from the evidence that
macrophages can exist in different activation states with
distinct properties (8). On stimulation with lipopolysac-
charide (LPS) and interferon-, macrophages assume a
proinflammatory classical activation profile also known as
M1. However, under the influence of TH2 cytokines inter-
leukin (IL)-4 or IL-13, macrophages assume an alternative
activation state (M2a) and produce immunosuppressive
factors, such as IL-10, IL-1RA, and arginase (9). We have
previously demonstrated that ATMs in lean mice are
polarized toward an alternatively activated state (M2a),
whereas ATMs in obese mice have an M1 profile (10). The
importance of this M1/M2a balance in glucose metabolism
has been illustrated in macrophage-specific Pparg/ mice
that have deficient M2a polarization, increased adipose
tissue inflammation, and worse insulin resistance (11,12).
How does obesity switch ATMs from an M2a to an M1
activation state? One hypothesis is that resident M2a
ATMs are uniformly converted to an M1 state. A second
hypothesis is that M1 ATMs are generated by the obesity-
induced trafficking of a subset of inflammatory CCR2
Ly6GhiCX3CR1low monocytes to fat similar to what is seen
in atherosclerotic lesions (13). Currently, there is insuffi-
cient information to differentiate between these two mod-
els. In this study, we provide evidence for the latter model
by characterizing subtypes of ATMs in lean and obese
mice. We identified a population of resident ATMs
expressing the M2a marker macrophage galactose N-
acetyl-galactosamine specific lectin 1 (MGL1/CD301)
that localizes to interstitial spaces between adipocytes.
High-fat diet feeding does not alter the presence of
MGL1 ATMs but instead induces the spatially re-
stricted accumulation of M1-polarized MGL1 ATMs in
clusters surrounding dead adipocytes. Kinetic studies
show that the rate of recruitment of these subtypes into
adipose tissue differs significantly and support a model
in which the M2a-to-M1 switch in ATMs is coupled to
differential monocyte/macrophage recruitment.
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RESEARCH DESIGN AND METHODS
Animal care and use. Male C57Bl/6 mice or Ccr2/ mice were fed a normal
chow (LabDiet 5001) or high-fat diet (45% kcal from fat, Research Diets) ad
libitum for 16–20 weeks from 8 weeks of age. Ccl2/ mice were provided by
D. Eitzmann (University of Michigan). Animals were housed in a specific
pathogen–free facility and given free access to food and water. All animal use
was in compliance with the Institute of Laboratory Animal Research Guide for
the Care and Use of Laboratory Animals and approved by the University
Committee on Use and Care of Animals at the University of Michigan.
Confocal microscopy. Mice were euthanized and slowly perfused by intra-
cardiac injection with 10 ml of 1% paraformaldehyde diluted in PBS. Small fat
pad samples were excised and blocked for 1 h in 5% BSA in PBS with gentle
rocking at room temperature. For detection of intracellular antigens, blocking
and subsequent incubations were done in 5% BSA in PBS with 0.3% Triton
X-100. Primary antibodies were diluted in blocking buffer to 0.5–1 g/ml and
added to fat samples for 2 h at room temperature or overnight at 4°C. After
three washes, fluorochrome-conjugated secondary antibodies were added for
1 h at room temperature, and nuclei were stained with TOPRO-3. Alexa
647–conjugated isolectin (Molecular Probes) was used to identify vascular
structures. Fat pads were imaged on an inverted confocal microscope
(Olympus Fluoview 300) by placing the pad in 95% glycerol in a chambered
coverslip. Anti-mouse antibodies used were against TLR4 and CCR2 (Santa
Cruz Biotechnology); CD11c, CD11b, and Caveolin1 (BD Biosciences); and
F4/80 and MGL1 (clone ER-MP23; Abcam).
Macrophage labeling with PKH26. PKH26 (Sigma) was prepared for
phagocytic labeling per the manufacturer’s instructions. One milliliter of 1
mol/l PKH26 was injected intraperitoneally into mice fed high-fat diet for 12
weeks. Clusters were imaged by taking 5- to 10-m z-sections, and
TOPRO3F4/80 cells were scored for PKH26 intracellular staining.
Flow cytometry and gene expression analysis. Flow cytometry on stromal
vascular fraction (SVF) cells and real-time RT-PCR analysis were performed
as previously described (10). Anti-mouse antibodies used were F4/80-PE-Cy5
(eBioscience) and CD301/MGL1 (ABDSerotec).
Macrophage conditioned media and adipocytes. Differentiation, 2-deoxy-
glucose uptake assays, and immunoblots of 3T3-L1 adipocytes were per-
formed as described previously (14). Bone marrow macrophages were derived
by culturing bone marrow suspensions in Dulbecco’s modified Eagle’s me-
dium with 10% heat-inactivated fetal bovine serum in the presence of 20% L929
conditioned medium for 7 days.
RESULTS
Resident ATMs reside between adipocytes and
express the M2a marker MGL1. We first examined the
properties of resident ATMs in lean mice. Consistent with
previous studies (10), we observed that ATMs in multiple
fat depots uniformly express MGL1, an established marker
of alternative M2a macrophage activation (Fig. 1A)
(15,16). MGL1 ATMs were uniformly F4/80 and CD11b
and resided in interstitial spaces between adipocytes in
lean mice (Fig. 1B). These ATMs were occasionally asso-
ciated with blood vessels but were not restricted to
FIG. 1. Resident M2a ATMs in lean mice are MGL1 and are recruited independent of CCR2/CCL2. Immunofluorescence localization of ATMs in
adipose tissue using confocal microscopy. Samples from male C57Bl/6 mice fed chow diet. Similar results were obtained from three to five
independent mice. Bar 50 m. A: MGL1 ATMs are present in interstitial spaces between adipocytes in multiple adipose tissue depots. Caveolin
staining (red) delineates adipocytes. B: MGL1 cells (red) are macrophages based on costaining with F4/80 (left panels) and CD11b (right
panel). Images from epididymal fat pads. C: Perivascular localization of a portion of MGL1 ATMs. Isolectin (red) labels endothelial cells to
highlight vasculature in fat. MGL1 ATMs express IL-10 (D) and CCR2 (E). F: MGL1 ATMs are retained in epididymal adipose tissue from
Ccl2/ and Ccr2/ mice. (Please see http://dx.doi.org/10.2337/db08-0872 for a high-quality digital representation of this figure.)
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perivascular regions (Fig. 1C). Reinforcing their M2a
polarization, MGL1 resident ATMs also express IL-10
(Fig. 1D).
To understand the mechanism of recruitment of MGL1
ATMs, we examined the expression of chemokine receptors
previously implicated in macrophage migration. MGL1
ATMs expressed CCR2 (Fig. 1E); however, the localization
and quantity of the MGL1 ATMs were not altered in visceral
fat pads from Ccr2/ and Ccl2/ mice (Fig. 1F). This
demonstrates that MGL1 ATMs are recruited to fat via
CCR2- and CCL2-independent mechanisms.
Obesity induces the accumulation of MGL1 ATMs in
adipose tissue while retaining MGL1 interstitial
ATMs. The M2a marker MGL1 permitted the examination
of how obesity biases ATMs toward an M1 activation state.
If obesity alters the phenotype of all resident ATMs, we
predicted that MGL1 expression might be decreased in all
ATMs with high-fat diet. However, we observed that MGL1
expression was retained in interstitial ATMs in high-fat
diet–fed mice, despite adipocyte hypertrophy and ongoing
adipocyte death (Fig. 2A). In contrast, ATMs in clusters
(“crown-like structures”) were uniformly MGL1. Occa-
sional MGL1 ATMs were observed toward the outer rim
of the clusters. To see if this heterogeneity of MGL1
expression is found in other models of obesity, ATMs in
db/db mice were examined and found to have an identical
distribution of MGL1 ATMs in interstitial spaces and
MGL1 ATMs confined to clusters (supplementary Fig. 1,
available in an online appendix at http://dx.doi.org/10.
2337/db08-0872).
The MGL1 ATMs in clusters were F4/80 and CD11b
and expressed high levels of inflammatory markers CD11c
and TLR4, although these were also expressed to some
degree in MGL1 ATMs (Fig. 2B–D). In contrast, MGL1
ATMs had high affinity for isolectin, a previously identified
marker for inflammatory ATMs (5), whereas MGL1 ATMs
FIG. 2. ATMs in clusters in obese mice are MGL1CCR2 and MGL1 ATMs are retained. Characterization of ATMs in high-fat diet (HFD)-fed
C57Bl/6 mice. Caveolin staining (blue) demonstrates loss of membrane integrity in lipid droplets. Staining patterns were observed in at least four
independent mice. Bar  50 m. A and B: Interstitial ATMs are retained with obesity and are uniformly MGL1F4/80CD11b. CD11c (C) and
TLR4 (D) are strongly expressed in MGL1 ATMs in clusters. Isolectin binding (E) and CCR2 expression (F) are increased in ATM clusters and
do not overlap with MGL1 expression. G: IL-10 expression is retained in interstitial ATMs and is downregulated in ATM clusters. H: Partial loss
of caveolin staining in a dying adipocyte surrounded by a thin wall of MGL1CD11c ATMs. I: Reduced numbers of ATM clusters in epididymal
fat in high-fat diet Ccr2/ mice. ATM clusters in Ccr2/ mice express CD11c similar to obese Ccr2/ mice. J: ATM clusters in Ccr2/ mice
downregulate MGL1 expression. (Please see http://dx.doi.org/10.2337/db08-0872 for a high-quality digital representation of this figure.)
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did not bind isolectin (Fig. 2E). MGL1 ATMs in clusters
also had high CCR2 expression, whereas the interstitial
MGL1 ATMs had low CCR2 expression (Fig. 2F). Con-
versely, IL-10 expression was prominent in interstitial
ATMs and downregulated in the ATM clusters (Fig. 2G).
Overall, these results suggest that M1 activation of ATMs is
spatially restricted to ATM clusters and is superimposed
on the MGL1 ATM population seen in lean mice.
ATM clusters were closely associated with vascular
structures (Fig. 2E) and surrounded lipid droplets from
dead adipocytes that were caveolin negative. Some adipo-
cytes were identified with a discontinuous distribution of
caveolin at the membrane and were surrounded by a thin
layer of macrophages, suggesting that this is an early
lesion (Fig. 2H). Uniformly, lipid droplets surrounded by
multiple layers of macrophages were caveolin negative,
consistent with coordinated regulation of M1 ATM clus-
tering and adipocyte death. This suggests that loss of
adipocyte membrane integrity is the likely initiating event
for MGL1 ATM accumulation.
To assess the importance of CCR2 for MGL1 ATM
accumulation, obese Ccr2/ mice were analyzed. Com-
pared with Ccr2/ mice, Ccr2/ mice had fewer ATM
clusters (Fig. 2I). However, the ATMs in these clusters
were similar to those seen in Ccr2/ mice in that they
were CD11c and MGL1 (Fig. 2J). In these mice, all
F4/80 ATMs were also CD11c (supplementary Fig. 2,
available in the online appendix). This suggests that CCR2-
independent mechanisms exist to recruit MGL1 ATMs to
clusters.
Diet-induced obesity induces the recruitment of M1-
polarized MGL1 ATMs into visceral fat. The imaging
data suggested that the primary difference between ATMs
in lean and obese mice is the accumulation of MGL1
ATMs. To confirm this, we analyzed the SVF from adipose
tissue from lean and obese mice by flow cytometry. Of
ATMs in both epididymal and subcutaneous fat pads from
lean mice, 80% were MGL1 (Fig. 3A). In high-fat diet–
fed mice, there was a decrease in the percentage of
MGL1 ATMs in epididymal fat (Fig. 3B). This decrease
was accompanied by a 2.5-fold increase in the percentage
of MGL1 ATMs in obese mice with high-fat diet. These
changes resulted in a shift in the ratio of M2a to M1 ATMs
from 4:1 in normal diet–fed mice to 1.2:1 in high-fat
diet–fed mice. We next examined ATMs from subcutane-
ous fat and found that the percentage of MGL1 ATMs was
not changed with high-fat diet in this fat depot. Like
visceral fat, high-fat diet induced the accumulation of
MGL1 ATMs in subcutaneous fat, but the accumulation
of MGL1 ATMs in subcutaneous fat was less than what
was observed for visceral fat.
To verify that MGL1 and MGL1 ATMs have different
activation profiles, gene expression was analyzed in the
two ATM populations isolated from obese mice. Com-
pared with MGL1 ATMs, MGL1 ATMs had increased
expression of M2a macrophage genes Il10, Arg1, and
Pgc1b (Fig. 3C). In contrast, MGL1 ATMs had signifi-
cantly higher expression of inflammatory genes Nos2 and
Il1b, consistent with a proinflammatory activation state.
Examination of other proinflammatory genes demon-
strated trends of higher expression of Ccl3 and Ccl4 in
MGL1 ATMs relative to MGL1 ATMs.
MGL1 ATMs are recruited to clusters at a faster
rate than MGL1 interstitial ATMs. The spatial sepa-
ration between MGL1 and MGL1 ATMs in obesity
suggests that these subtypes are recruited to adipose
tissue via different mechanisms. To evaluate this, we used
PKH26 labeling to identify newly recruited ATMs. Mice
were injected with PKH26 that label ATMs with near 100%
efficiency (17). Because this inert dye is taken up by
macrophages and not monocytes (18), ATMs recruited to
adipose tissue after the time of injection can be identified
as F4/80PKH26 cells. Because this experiment is depen-
dent on similar rates of retention of the PKH26 dye in M1-
and M2-polarized macrophages, we examined PKH26 dye
staining in macrophages stimulated with vehicle, LPS, or
IL-4 (supplementary Fig. 3, available in the online appen-
dix). This demonstrated that the intracellular retention of
PKH26 dye was not altered by macrophage activation with
LPS or IL-4 for up to 7 days.
After 12 weeks of high-fat diet feeding, mice were
injected with PKH26 and were analyzed at different times
after injection for F4/80PKH26 ATMs. Three days after
injection, almost all ATMs in both clusters and interstitial
spaces were PKH26 (Fig. 4A). With increasing time after
injection, the percentage of PKH26 ATMs in the clusters
steadily increased, which suggests that new ATMs were
recruited specifically to the clusters (Fig. 4B). In contrast,
the proportion of PKH26 ATMs in interstitial spaces
remained low throughout the time course, suggesting that
ATMs traffic to interstitial areas at a significantly slower
rate than they traffic to clusters.
These results suggested that MGL1 expression defines
the differentially recruited ATM subtypes identified by
PKH26 labeling. By confocal microscopy, the majority of
the PKH26 ATMs in clusters were MGL1, and interstitial
cells with retained PKH26 label were MGL1 (Fig. 4C). To
confirm this, ATMs were analyzed by flow cytometry 28
days after PKH26 injection (Fig. 4D). This showed that
PKH26F4/80 ATMs were MGL1, whereas PKH26F4/
80 had low MGL1 expression.
To assess how CCR2 deficiency alters these recruitment
dynamics, we injected high-fat diet–fed Ccr2/ mice with
PKH26 and analyzed the appearance rate of ATMs in
clusters and in interstitial spaces. The percentage of
PKH26F4/80 cells in clusters 28 days after injection
from Ccr2/ mice was decreased compared with Ccr2/
mice, which suggests that ATMs are recruited to clusters
at a slower rate in the absence of CCR2 (Fig. 4E). The
accumulation of new interstitial ATMs was not altered
in Ccr2/ mice, consistent with our previous results
(Fig. 1F).
M1- and M2a-activated macrophages have different
effects on adipogenesis and glucose uptake. The dif-
ferences between ATM subsets suggest that M1 and M2a
macrophages may have different effects on adipocyte
function. To test this, we used conditioned media from
untreated, LPS-stimulated (M1), and IL-4–stimulated
(M2a) macrophages in assays with 3T3-L1 adipocytes.
These activation conditions generated the expected mac-
rophage phenotypes: LPS stimulated tumor necrosis fac-
tor- and IL-12 production, whereas IL-4 induced arginase
and MGL1 (data not shown). Insulin-stimulated glucose
uptake was inhibited by M1 conditioned medium but not
with conditioned media from M2a or unstimulated macro-
phages (Fig. 5A). Additionally, when preadipocytes were
differentiated in the presence of conditioned media condi-
tions, we observed similarly that whereas M1 conditioned
medium effectively inhibited adipogenesis, conditioned
media from control and M2a macrophages were permis-
sive to adipogenesis even when added at high concentra-
tions (Fig. 5B and C).
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DISCUSSION
Our studies address several gaps in what is known about
ATMs. Our data demonstrate that ATMs in lean mice
extensively localize to interstitial spaces between adipo-
cytes and reinforce the concept that ATMs are a funda-
mental component of adipose tissue even in lean states.
These “resident ATMs” uniformly express markers of M2a
alternative activation, MGL1 and IL-10. MGL1 is strongly
induced by IL-4/IL-13 in macrophages in vitro but is
expressed in dermal macrophages independent of IL-4 or
IL-13, suggesting that multiple inputs regulate MGL1 ex-
pression (15). MGL1 is expressed in a subtype of macro-
phages involved in granuloma formation, and Mgl1/
mice demonstrate defective tissue repair after injury,
consistent with the proposed role for M2a macrophages in
tissue remodeling (19).
MGL1 ATMs are poised to communicate directly with
adipocytes, and our in vitro experiments suggest that
macrophage activation state is an important variable in
this communication. The permissive nature of M2a-polar-
ized conditioned medium on glucose uptake and adipogen-
esis is consistent with the notion that in lean settings,
MGL1 ATMs promote an environment favorable for new
fat cell formation. The inhibition of these processes by M1
macrophages may instead ultimately promote adipocyte
hypertrophy and death, which has been closely linked to
ATM accumulation (20).
Obesity does not significantly alter the localization of
MGL1 ATMs in adipose tissue but instead superimposes
a new population of M1-polarized MGL1CCR2 ATMs on
these resident cells. A decrease in the quantity of M2a
ATMs combined with the appearance of these “recruited
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FIG. 3. Obesity induces the recruitment of M1 MGL1 ATMs to adipose tissue. A: Accumulation of MGL1 ATMs with high-fat diet (HFD) feeding.
SVF was isolated from epididymal fat pads and stained to identify MGL1 and MGL1 F4/80 ATMs. Percentages of total SVF provided from a
representative experiment. Similar results were observed for six animals per group. B: Induction of MGL1F4/80 ATMs with obesity is more
pronounced in visceral compared with subcutaneous fat. ATM MGL1 subtypes were quantitated by flow cytometry and expressed as a percentage
of SVF, total cells per fat pad, and total cells per gram fat. Visceral fat from epididymal fat pads (Epi) were compared with subcutaneous fat (SQ)
from the inguinal fat pad. n  6 per group. Values are expressed as means  SE. *P < 0.05. **P < 0.005. C: Differential inflammatory gene
expression between ATM subtypes shows M2a polarization of MGL1 ATMs. MGL1 and MGL1 ATMs were isolated by fluorescence-activated
cell sorting, and RNAs were prepared for real-time RT-PCR analysis. Gene expression is expressed as relative to MGL1 ATMs. M2a genes (left
panel) and M1 genes (right panels) were analyzed. n  4 per group. Values are expressed as means  SE. *P < 0.05. A.U., arbitrary units; ND,
normal diet.
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ATMs” ultimately shifts the balance of M1/M2a ATMs to
create a more proinflammatory environment in adipose
tissue. PKH26 labeling shows that this recruitment is
highly spatially restricted to clusters and is consistent with
intravital microscopy data that show increased leukocyte
trafficking into adipose tissue with obesity (21). We note
that it has been reported that isolectin does not label
inflammatory clusters of macrophage in the crown-like
structures (22). In our experiments, we did not identify
heterogeneity in isolectin binding to the clusters because
nearly 100% of all clusters are isolectin positive. This may
be due to technical differences in the staining approach or
differences in the models used (db/db in ref. 22 and
diet-induced obesity in our study).
Although it has been suggested that macrophages can be
converted between M1 and M2a states (23), our results do
not support this notion for ATMs. The restricted distribu-
tion of M1 and M2a ATM subtypes instead support a model
where obesity induces the specific migration of inflamma-
tory CCR2Ly6GhiCX3CR1low monocytes from the circu-
lation to ATM clusters. This is similar to what has been
proposed to mediate monocyte/macrophage recruitment
to atherosclerotic plaques (24,25). Another hypothesis that
we considered was that resident MGL1 ATMs migrate
from their interstitial position to the clusters and are
subsequently converted to an M1 state. Pulse-labeling
ATMs with PKH26 did not support this. If resident ATMs
migrate from their interstitial position toward clusters
over time, we would expect to observe an increase in
PKH26 ATMs in the clusters after labeling and a gradual
replacement of interstitial ATMs with PKH26 ATMs. This
is not what we observed. Although it is possible that
PKH26 is metabolized differently in M1 and M2a ATMs,
which would confound our results, in vitro experiments
FIG. 4. MGL1 ATMs are preferentially recruited to clusters with high-fat diet feeding. A and B: Pulse labeling of ATMs demonstrates recruitment
of ATMs to clusters and not interstitial sites with high-fat diet feeding. A: High-fat diet–fed C57Bl/6 mice were injected with PKH26 to label ATMs
in visceral fat and analyzed by confocal microscopy at the indicated time after injection. Imaging focused either on ATM clusters (top) or
interstitial areas (bottom). PKH26 ATMs accumulate in clusters while the interstitial ATMs retain PKH26 as long as 28 days after labeling. B:
Quantitation of PKH26F4/80 ATMs during time course. From two to three mice per time point, 25–30 clusters or high-power fields were
analyzed and scored for the percentage of PKH26 ATMs. **P < 0.005 vs. interstitial. C and D: MGL1 ATMs preferentially retain PKH26. C:
Immunofluorescence on mice 28 days after PKH26 injection, demonstrating the retention of dye in MGL1 ATMs. PKH26 ATMs are primarily
MGL1CD11c cells in clusters. D: Flow cytometry of SVF from mice 28 days after PKH26 injection. PKH26 gates (W0) were defined by
comparing ATMs from uninjected (white) versus PKH26 injected (yellow) mice 3 days after injection. PKH26 (R1) and PKH26 (R2) ATMs
(F4/80) were gated and examined for MGL1 expression. PKH26 ATMs have high MGL1 expression compared with low MGL1 expression in
PKH26 ATMs. Representative experiment is shown from one of three independent experiments. E: Decreased rate of recruitment of ATMs to
clusters in obese Ccr2/ mice. Ccr2/ mice were analyzed 28 days after injection by microscopy and scored for the percentage of PKH26 ATMs
in clusters or interstitial areas. *P < 0.05 vs. Ccr2/ mice. (Please see http://dx.doi.org/10.2337/db08-0872 for a high-quality digital
representation of this figure.)
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did not show that M1 activation per se leads to the loss of
the PKH26 dye from macrophages.
Our studies suggest that specifically targeting MGL1
ATMs can potentially decrease high-fat diet–induced in-
flammation in adipose tissue. Blockade of CCR2 has been
proposed as one way to accomplish this (2). In this regard,
PKH26 labeling showed that Ccr2/ mice have a de-
creased rate of accumulation of ATMs in clusters. This is
consistent with the evidence that Ccr2/ mice have few
circulating CCR27/4Ly6G monocytes because of de-
fective migration out of the bone marrow (13). However,
ATM cluster formation is not completely abolished in the
absence of CCR2, and these ATMs are still
CD11cMGL1F4/80. Therefore, it appears that MGL1
ATMs can be recruited to clusters via CCR2-independent
signaling pathways, although CCR2 deficiency may limit
this process. This may explain some of the conflicting
results published on ATMs in obese Ccl2/ mice (26,27).
Studies have yet to conclusively support or refute the
validity of the M1/M2a model in human ATMs. Consistent
with our studies, Bourlier et al. (28) identified ATM
subtypes in subcutaneous fat with differential expression
of the M2a markers CD206 and CD16 and found that
adipose tissue expansion correlated with the accumula-
tion of CD206CD16 ATMs. In contrast, Zeyda et al. (29)
failed to identify subsets of ATMs and argued that the
ATMs were homogeneous. Both studies failed to identify
ATM subtypes with a strict M1 or M2a bias. These studies
emphasize that although the identification of M1 and M2a
macrophages is fairly mature in mice, it is still unclear how
this paradigm applies to human diseases.
Overall, we provide evidence that subtypes of ATMs
account for the M2a-to-M1 switch in obesity and can be
distinguished by differences in kinetics of accumulation in
fat, spatial localization, MGL1 expression, and inflamma-
tory gene expression. This adds to our understanding of
ATM biology and provides specific targets for potential
intervention. The goal of future studies will be to dissect
the molecular signals that govern the migration and re-
cruitment of MGL1 and MGL1 ATMs and to validate this
heterogeneity in human adipose tissue.
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